Company / Working Capital per Share
Vertex Pharmaceuticals Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$28.57
FY2025
5-year range
$23.41 / $41.23
FY2021-FY2025
Trend
+22.0%
vs FY2024
Sector context
#13 of 210
Health Care
What the data says
Among 210 Health Care companies, Vertex Pharmaceuticals is in the top 6% for working capital per share. Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $28.57.
Based on SEC 10-K filings.
28.57 in FY2025 with a 5-year CAGR of +3.4%. Top quartile in the Health Care sector.
Declined from $41.23 to $28.57 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -11.5%
- 5-Year CAGR
- +3.4%
- 10-Year CAGR
- -
Sector benchmark
-80.5% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 22.0% year-over-year.
- Ranks #13 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.57 | +22.0% |
| FY2024 | $23.41 | -43.2% |
| FY2023 | $41.23 | -0.0% |
| FY2022 | $41.23 | +44.4% |
| FY2021 | $28.55 | +18.2% |
| FY2020 | $24.15 | +76.7% |
| FY2019 | $13.67 | +27.1% |
| FY2018 | $10.75 | +45.0% |
| FY2017 | $7.42 | +75.8% |
| FY2016 | $4.22 | +13.2% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026